We hold several webinars a year, with international experts discussing latest research and developments. These webinars use BMJ Best Practice, a point of care tool to get fast and easy evidence-based answers to clinical questions, helping you make the right decisions at the point of care. Click here to find out more.
To be announced soon.
Hypercholesterolaemia: Current Best Practice in Evaluation & Management
With expert: Dr Seth S. Martin, MD, MHS, FACC, FAHA
Assistant Professor of Medicine/Cardiology, Co-Director, Lipid Clinic, Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD
Hypercholesterolaemia is an established risk factor for cardiovascular disease. In this webinar, our clinical experts will discuss the current approach to diagnosis and management of hypercholesterolaemia; statins as first-line pharmacotherapy; and the place for newer treatment options.
By watching this webinar, you will learn about:
- Screening, classification and key diagnostic factors
- Statins to reduce LDL-C and lipid-related CV risk
- The role of non-statin agents such as PCSK9 inhibitors for this condition.
BMJ - Update on stroke prevention for non-valvular AF
With experts: Dr. Arti N. Shah and Dr. Bharat K. Kantharia
The thromboembolic stroke rate in patients with non-valvular atrial fibrillation (AF) increases progressively as estimated by the CHADS2 and CHA2DS2-VASc score systems. Hence, a major focus in the management of such patients is prevention of stroke. In this webinar, we discuss the role of newer pharmacological agents (NOACs), non-pharmacological methods, cardiac devices and left atrial appendage occlusion in stroke prevention.
Adults with type 2 diabetes are twice as likely to die of stroke or myocardial infarction as those without diabetes, and they are more than 40 times more likely to die of macrovascular than microvascular complications. A primary goal of care is to address cardiovascular (CV) risk factors, including smoking cessation and blood pressure control, as well as statin and aspirin use. Meanwhile, ongoing studies are changing our understanding of how glucose-lowering therapies may impact CV risk. In this webinar, we discuss the impact of antihyperglycemic agents, aspirin, lipid lowering treatment and blood pressure control in diabetes risk.
This webinar presented by Dr Syed Wamique Yusuf, MRCPI, FACC and Dr Sheila Feit, MD focuses on the diagnosis and treatment of chronic heart failure in primary care. It also covers the use BMJ Best Practice to cover classification, diagnosis, key findings, evidence-based treatment, medicine to improve QOL and improvement in mortality vs symptomatic relief (e.g., diuretic, digoxin).
Despite great progress with new therapies in improving patient outcomes, type 2 diabetes is still a complex and challenging disease requiring individualisation. This video shows you how you can manage type 2 diabetes in adults. Topics include discussions around current management guidelines and the underlying evidence. Using BMJ Best Practice the following areas are discussed; epidemiology, screening and risk factors, treatment of cardiovascular risk factors such as blood pressure and lipids, management of hyperglycaemia and prevention and emerging treatments.